Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kadmon Corp. LLC

www.kadmon.com

Latest From Kadmon Corp. LLC

Keeping Track: Pfizer’s Talzenna Ensures Record Year For Novel US Approvals; Novartis Submits SMA Gene Therapy

The latest drug development news and highlights from our FDA Performance Tracker.

Drug Review Approvals

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Phase III Readouts For Talazoparib, Ampion, Avatrombopag

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Deals Shaping The Medical Industry, October 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2017.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Immune Disorders
  • Metabolic Disorders
  • Ophthalmic
  • Renal System
  • Respiratory, Pulmonary
  • Alias(es)
  • Kadmon Pharmaceuticals LLC
  • Kadmon Holdings Inc
  • Kadmon Holdings LLC
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Kadmon Corp. LLC
  • Senior Management
  • Harlan W Waksal, MD, Pres. & CEO
    Konstantin Poukalov, CFO
    Lawrence K Cohen, PhD, EVP, Bus. Dev.
    Larry Witte, PhD, EVP, R&D
    Eva Heyman, SVP, Chief Commercial Officer
    John Ryan, MD, PhD, EVP, CMO
  • Contact Info
  • Kadmon Corp. LLC
    Phone: (212) 308-6000
    450 E. 29th St.
    5th Fl.
    New York, NY 10016
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register